PTPN11 and Hepatic fibrosis: Furthermore, SHP2 inhibition was reported to downregulate the phosphorylation of platelet-derived growth factor receptor α (PDGFRα) derived from HSCs, thus reducing liver fibrosis (Kostallari et al., 2018).